Opioids for cancer pain: The challenge of optimizing treatment

Metabolism: Clinical and Experimental

Volumn 59, Issue SUPPL. 1, 2010, Pages

  Plante, Gérard E ^a   Vanitallie, Theodore B ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; ENDORPHIN; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; TRAMADOL; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANALGESIA; BREAKTHROUGH PAIN; CANCER PAIN; CHRONIC PAIN; CONSTIPATION; DISEASE SEVERITY; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; EUPHORIA; HUMAN; NAUSEA AND VOMITING; NERVE STIMULATION; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; FEMALE; MALE; NEOPLASM; PAIN, INTRACTABLE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE;

ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; NEOPLASMS; OPIOID PEPTIDES; PAIN, INTRACTABLE; PREVALENCE; RECEPTORS, OPIOID;

EID: 77956595414     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.07.010     Document Type: Article

References (33)

1. Melzack R., and Wall P.D. The challenge of pain. Penguin 2008 53 54 [updated 2nd edition]
2. Messina J., Darwish M., and Fine P.G. Fentanyl buccal tablet Drugs Today (Barc) 44 2008 41 54
3. Portenoy R.K. Cancer pain: epidemiology and syndromes Cancer 63 1989 2298 2307
4. http://www.oncologychannel.com/pain/index.shtml
5. Twycross R.G., and Fairfield S. Pain in far-advanced cancer Pain 14 1982 303 310
6. http://info.cancerresearchUK.org/cancerstats/incidence/age/
7. SEER cancer statistics review 1975-2007, National Cancer Institute
8. Apkarian A.V., Bushnell M.C., Treede R.D., and Zubieta J.K. Human brain mechanisms of pain perception and regulation in health and disease Eur J Pain 9 2005 463 484
9. http://www.cancer.gov/cancertopics/pdq/supportivecare/pain/Patient/page5
10. Pfister D.G., Cassileth B.R., and Deng G.F. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial J Clin Oncol 2010 [Epub ahead of print]
11. Glick R.M., and Greco C.M. Biofeedback and primary care Prim Care 37 2010 91 103
12. th Annual Scientific Meeting: abstract 309. Presented May 6, 2010.
13. Stoelb B.L., Molton I.R., Jensen M.P., and Patterson D.R. The efficacy of hypnotic analgesia in adults: a review of the literature Contemp Hypn 26 2009 24 39
14. Huang S.T., Good M., and Zauszniewski J.A. The effectiveness of music in relieving pain in cancer patients: a randomized controlled trial Int J nurs Stud 2010 [Epub ahead of print]
15. Kwekkeboom K.L., Cherwin C.H., Lee J.W., and Wanta B. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer J Pain Symptom Manage 39 2010 126 133
16. World Health Organization Cancer pain relief and palliative care: report of a WHO Expert Committee 1990 World Health Organization Geneva 7 21
17. Krenzelok E.P. The FDA Acetaminophen Advisory Committee Meeting-what is the future of acetaminophen in the United States? The perspective of a committee member Clin Toxicol (Phila) 47 2009 784 789
18. Pergolizzi J., Boger R.E.H., and Budd K. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone) Pain Pract 8 2008 287 313
19. Lawson E.F., and Wallace M.S. Current developments in intraspinal agents for cancer and noncancer pain Curr Pain Headache Rep 14 2010 8 16
20. Mercadante S., Porzio G., and Ferrera P. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management Eur J Pain 12 2008 1040 1046
21. Mercadante S., Intravaia G., and Villan P. Intravenous morphine for breakthrough (episodic-C) pain in an acute palliative care unit. A confirmatory study J Pain Symptom Manage 35 2008 307 313
22. Weinstein S.M., Messina J., and Xie F. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain Cancer 115 2009 2571 2579
23. Vissers D., Stam W., Nolte T., Lenre M., and Jansen J. Efficacy of intrasal fentanyl spray versus other opioids for breakthrough pain in cancer Curr Med Res Opin 26 2010 1037 1046
24. R. Dean, E.J. Bilsky, S.S. Negus, Opiate receptors and antagonists: from bench to clinic 2009 Humana Press Totowa, NJ
25. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors Annu Rev Biochem 73 2004 953 990
26. Smith H.S. Opioid metabolism Mayo Clin Proc 84 2009 613 624
27. Hanks G.W. Morphine and alternate opioids in cancer pain. The EAPC recommendations Br J Cancer 84 2001 587 593
28. Millan M.J. Descending control of pain Prog Neurobiol 66 2002 385 474
29. Okada Y., Tsuda Y., Bryant S.D., and Lazarus L.H. Endomorphins and related opioid peptides Vitam Horm 65 2002 257 279
30. Zadina J.E., Martin-Schild S., and Gerall A.J. Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density Ann N Y Acad Sci 897 1999 136 144
31. Thanawala V., Kadam V.J., and Ghosh R. Enkephalinase inhibitors: potential agents for the management of pain Curr Drug Targets 9 2008 887 894
32. Popik P., J. Kamysz Kreczko, and Wrobel M. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice Behav Brain Res 2010 [Epub ahead of print]
33. Berger A.C., and Whistler J.L. How to design an opioid drug that causes reduced tolerance and dependence Ann Neurol 67 2010 559 569